Skip to main content
Go to the home page of the European Commission (opens in new window)
English English
CORDIS - EU research results
CORDIS
Content archived on 2024-05-27

Development of anti-melanoma therapies: the animal model stage.

Objective

Susceptibility genes and environmental factors contribute to the rising incidence of melanoma in Europe. Tumor associated antigens on melanomas can be recognized by immune effectors. These antigens are the focus of immunotherapy protocols. Information is lacking, however, concerning expression of tumour associated antigens and the activation status of immune effectors at initial stages of tumour suppressor gene in melanocytes. The concordant expression of a tumour associated antigen will allow monitoring of the activation status of antigen-specific lymphocytes during tumour progression. This information is essential for the design of tumour antigen vaccination and other therapeutic protocols. This project requires a pluridisciplinary effort by groups involved in
(i) development of models of oncogenesis by somatic genetics in mice;
(ii) identification of melanoma associated antigens in humans and;
(iii) monitoring activation or inactivation in vivo and targeting of immune effectors or antigen presenting cells.

Fields of science (EuroSciVoc)

CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.

You need to log in or register to use this function

Topic(s)

Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.

Call for proposal

Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.

Data not available

Funding Scheme

Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.

CSC - Cost-sharing contracts

Coordinator

CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
EU contribution
No data
Address
Parc Scientifique et Technologique de Luminy
13288 MARSEILLE
France

See on map

Total cost

The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.

No data

Participants (2)

My booklet 0 0